Okada M. Big data and real-world data-based medicine in the management of hypertension. Hypertens Res. 2021;44:147–53.

Article  PubMed  Google Scholar 

Tonegawa-Kuji R, Kanaoka K, Iwanaga Y. Current status of real-world big data research in the cardiovascular field in Japan. J Cardiol. 2023;81:307–15.

Article  PubMed  Google Scholar 

Hiramatsu K, Barrett A, Miyata Y, PhRMA Japan Medical Affairs Committee Working Group. Current status, challenges, and future perspectives of real-world data and real-world evidence in Japan. Drugs Real World Outcomes. 2021;8:459–80.

Article  PubMed  PubMed Central  Google Scholar 

Food and Drug Administration (United States). “Framework for fda’s real-world evidence program,” 2018. https://www.fda.gov/media/120060/download. Accessed 12 Jul 2024.

Cave A, Kurz X, Arlett P. Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin Pharm Ther. 2019;106:36–9.

Article  Google Scholar 

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). https://www.ich.org/. Accessed 12 Jul 2024.

International Coalition of Medicines Regulatory Authorities (ICMRA). https://www.icmra.info/drupal/. Accessed 12 Jul 2024.

Ishii M, Sakamoto W, Togo K, Nakazawa T, Shimazaki T, Tanaka M, et al. Regulations and case study of real world data for regulatory decision-making in Japan and the US. Regul Sci Med Prod. 2021;11:27–41.

Google Scholar 

Maeda H, Ng DB. Regulatory approval with real-world data from regulatory science perspective in Japan. Front Med. 2022;9:864960.

Article  Google Scholar 

The Ministry of Health Labour and Welfare. Amendment of regulation for good post marketing study practice for pharmaceuticals and medical devices (in Japanese). https://www.pmda.go.jp/files/000220766.pdf. Accessed 12 Jul 2024.

Sinnott SJ, Douglas IJ, Smeeth L, Williamson E, Tomlinson LA. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care. BMJ. 2020;371:m4080.

Article  PubMed  PubMed Central  Google Scholar 

Gitsels LA, Kulinskaya E, Bakbergenuly I, Steel N. Optimal SBP targets in routine clinical care. J Hypertens. 2019;37:837–43.

Article  CAS  PubMed  Google Scholar 

McAlister FA, Lethebe BC, Leung AA, Padwal RS, Williamson T. Visit-to-visit blood pressure variability is common in primary care patients: Retrospective cohort study of 221,803 adults. PLoS ONE. 2021;16:e0248362.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponjoan A, Blanch J, Fages-Masmiquel E, Marti-Lluch R, Alves-Cabratosa L, Garcia-Gil MDM, et al. Sex matters in the association between cardiovascular health and incident dementia: evidence from real world data. Alzheimers Res Ther. 2024;16:58.

Article  PubMed  PubMed Central  Google Scholar 

Satoh M, Murakami T, Obara T, Metoki H. Time-series analysis of blood pressure changes after the guideline update in 2019 and the coronavirus disease pandemic in 2020 using Japanese longitudinal data. Hypertens Res. 2022;45:1408–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The Ministry of Health Labour and Welfare. Overview of medical service regime in Japan. https://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/01_eng.pdf. Accessed 12 Jul 2024.

Satoh M, Hirose T, Nakayama S, Murakami T, Takabatake K, Asayama K, et al. Blood pressure and chronic kidney disease stratified by gender and the use of antihypertensive drugs. J Am Heart Assoc. 2020;9:e015592.

Article  PubMed  PubMed Central  Google Scholar 

Kaneko H, Itoh H, Yotsumoto H, Kiriyama H, Kamon T, Fujiu K, et al. Association of isolated diastolic hypertension based on the cutoff value in the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines with subsequent cardiovascular events in the general population. J Am Heart Assoc. 2020;9:e017963.

Article  PubMed  PubMed Central  Google Scholar 

Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, et al. Association of blood pressure classification using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with risk of heart failure and atrial fibrillation. Circulation. 2021;143:2244–53.

Article  CAS  PubMed  Google Scholar 

Toyama M, Satoh M, Nakayama S, Hashimoto H, Muroya T, Murakami T, et al. Combined effects of blood pressure and glucose status on the risk of chronic kidney disease. Hypertens Res. 2024;47:1831–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22:118–27.

Article  PubMed  PubMed Central  Google Scholar 

Ishimura N, Inoue K, Maruyama S, Nakamura S, Kondo N. Income level and impaired kidney function among working adults in Japan. JAMA Health Forum. 2024;5:e235445.

Article  PubMed  PubMed Central  Google Scholar 

Mori Y, Mizuno A, Fukuma S. Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study. Hypertens Res. 2024;47:1546–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamaguchi M, Inomata S, Harada S, Matsuzaki Y, Kawaguchi M, Ujibe M, et al. Establishment of the MID-NET((R)) medical information database network as a reliable and valuable database for drug safety assessments in Japan. Pharmacoepidemiol Drug Saf. 2019;28:1395–404.

Article  PubMed  PubMed Central  Google Scholar 

Medical and healthcare database utilization committee, Japanese Society for Pharmacoepidemiology. Survey of Japanese databases in Japan available for clinical/pharmacoepidemiology. https://www.jspe.jp/committee/kenkou-iryou/. Accessed 12 Jul 2024.

Yamada MH, Fujihara K, Kodama S, Sato T, Osawa T, Yaguchi Y, et al. Associations of systolic blood pressure and diastolic blood pressure with the incidence of coronary artery disease or cerebrovascular disease according to glucose status. Diabetes Care. 2021;44:2124–31.

Article  CAS  PubMed  Google Scholar 

Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, et al. Interaction of blood pressure and glycemic status in developing cardiovascular disease: analysis of a nationwide real-world database. J Am Heart Assoc. 2023;12:e026192.

Article  PubMed  Google Scholar 

Maeda T, Nishi T, Funakoshi S, Tada K, Tsuji M, Satoh A, et al. Risk of stroke in atrial fibrillation according to sex in patients aged younger than 75 years: a large-scale, observational study using real-world data. Heart Lung Circ. 2021;30:963–70.

Article  PubMed  Google Scholar 

Maeda T, Nishi T, Funakoshi S, Tada K, Tsuji M, Satoh A, et al. Risks of bleeding and stroke based on CHA2DS2-VASc scores in Japanese patients with atrial fibrillation: a large-scale observational study using real-world data. J Am Heart Assoc. 2020;9:e014574.

Article  PubMed  PubMed Central  Google Scholar 

Yoshida S, Tanaka S, Okada M, Ohki T, Yamagishi K, Okuno Y. Development and validation of ischemic heart disease and stroke prognostic models using large-scale real-world data from Japan. Environ Health Prev Med. 2023;28:16.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki Y, Kaneko H, Okada A, Itoh H, Fujiu K, Michihata N, et al. Risk for proteinuria in newly defined hypertensive people based on the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. Am J Cardiol. 2022;168:83–89.

Article  PubMed  Google Scholar 

Suenaga T, Satoh M, Murakami T, Hirose T, Obara T, Nakayama S, et al. Cross-classification by systolic and diastolic blood pressure levels and chronic kidney disease, proteinuria, or kidney function decline. Hypertens Res. 2023;46:1860–9.

Article  CAS  PubMed  Google Scholar 

Nakayama S, Satoh M, Tatsumi Y, Murakami T, Muroya T, Hirose T, et al. Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults. Atherosclerosis. 2021;330:107–13.

Article  CAS  PubMed  Google Scholar 

Rogers AS. Adverse drug events: identification and attribution. Drug Intell Clin Pharm. 1987;21:915–20.

CAS  PubMed  Google Scholar 

Agusti A, Cereza G, de Abajo FJ, Macia MA, Sacristan JA. Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs. Pharm Res. 2023;197:106967.

Article  CAS  Google Scholar 

Satoh M, Hirose T, Satoh H, Nakayama S, Obara T, Murakami T, et al. Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function i